hims retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide study sees significant weight

[84] However, healthcare providers should thoroughly discuss potential side effects with patients and establish appropriate monitoring protocols to ensure safe and effective treatment

Wegovy comes as a sterile solution, but removing the cap can introduce germs, which may increase the risk of infection

NewsHealth Weight loss drug GLP-1 may have potential to treat depression, improve motivation, study suggests The blockbuster GLP-1 drugs taken by many Americans for diabetes and to aid in weight loss may also have potential for treating major depression, a new study finds

Genetic predispositions to insulin resistance (variants in GIPR and GLP1R genes) and elevated FTO-associated weight gain risk may provide additional clinical context